Lucia Kucerova

Bratislava, BL, Slovakia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 27, 2026

Therapeutic targeting of folate receptor alpha (FRα) by antibody-polymer-drug conjugate in testicular germ cell tumors.

Therapeutic targeting of folate receptor alpha (FRα) by antibody-polymer-drug conjugate in testicular germ cell tumors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 12, 2026

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 19, 2026

Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Journal: PloS one

Published: December 31, 2025

Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors.

Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 26, 2025

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves (Leverages) cisplatin treatment efficacy.

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves (Leverages) cisplatin treatment efficacy.

Journal: PloS one

Published: June 11, 2025

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Journal: PloS one

Published: June 11, 2025

Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.

Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: May 26, 2025

Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells.

Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells.

Journal: Cells

Published: November 28, 2024

Antibody-drug conjugates as a novel therapeutic modality to treat recurrent refractory germ cell tumors.

Antibody-drug conjugates as a novel therapeutic modality to treat recurrent refractory germ cell tumors.

Journal: American journal of physiology. Cell physiology

Published: June 24, 2024

Association between glutathione S-transferases M1 expression and treatment outcome in germ cell tumor patients.

Association between glutathione S-transferases M1 expression and treatment outcome in germ cell tumor patients.

Journal: Neoplasma

Published: June 09, 2024

The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells.

The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells.

Journal: Neoplasma

Published: May 23, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026